Renal failure in chronic liver disease and the hepatorenal syndrome

Br J Hosp Med (Lond). 2011 Sep;72(9):497-503. doi: 10.12968/hmed.2011.72.9.497.
No abstract available

Publication types

  • Review

MeSH terms

  • Bilirubin / blood
  • Chronic Disease
  • Evidence-Based Practice
  • Fluid Therapy / methods*
  • Hemodynamics*
  • Hepatorenal Syndrome* / classification
  • Hepatorenal Syndrome* / etiology
  • Hepatorenal Syndrome* / metabolism
  • Hepatorenal Syndrome* / physiopathology
  • Hepatorenal Syndrome* / therapy
  • Humans
  • Kidney / blood supply
  • Liver / blood supply
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / physiopathology
  • Liver Transplantation*
  • Lypressin / administration & dosage
  • Lypressin / adverse effects
  • Lypressin / analogs & derivatives*
  • Monitoring, Physiologic
  • Patient Selection
  • Portasystemic Shunt, Surgical*
  • Regional Blood Flow / drug effects
  • Renal Insufficiency* / diagnosis
  • Renal Insufficiency* / etiology
  • Renal Insufficiency* / metabolism
  • Renal Insufficiency* / physiopathology
  • Renal Insufficiency* / therapy
  • Serum Albumin / analysis
  • Serum Albumin / metabolism
  • Severity of Illness Index
  • Terlipressin
  • Vasoconstrictor Agents / administration & dosage
  • Vasoconstrictor Agents / adverse effects

Substances

  • Serum Albumin
  • Vasoconstrictor Agents
  • Lypressin
  • Terlipressin
  • Bilirubin